review Eur Surg (2017) 49:149–157 DOI 10.1007/s10353-017-0471-3 A systematic review Guillermo Becerril-Martinez · Gregory L. Falk · Mario D’Souza Received: 5 June 2016 / Accepted: 21 February 2017 / Published online: 24 March 2017 © Springer-Verlag Wien 2017 Summary Results Our literature search identiﬁed 425 potentially Background Stents are widely used in the pallia- relevant reports and articles on patients who had un- tive treatment of esophageal malignant diseases for dergone stenting in neoadjuvant therapy, of which dysphagia. Their safety and efﬁcacy in the curative 14 studies (n = 430 patients) met the inclusion cri- neoadjuvant setting while induction therapy is under- teria for analysis. A total of 430 patients were iden- way have not been established. Concerns have been tiﬁed undergoing stenting and neoadjuvant therapy raised about a low frequency of curative surgery and with intention to cure. Resection was determined in poor survival outcomes when stenting has been used 250 patients in a highly heterogeneous group and was as a pathway to neoadjuvant therapy. achieved in 46.9% of patients (95% CI: 22.8–71.8). The Methods A systematic review was undertaken to variability of the resection proportion in the reports identify patients with esophageal cancer undergo- was very wide.
European Surgery – Springer Journals
Published: Mar 24, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera